Pirenzepine - AC Immune
Alternative Names: ACI-91; PSY-130; PSY-130/131; PSY-131Latest Information Update: 15 Jan 2014
At a glance
- Originator ProteoSys
- Developer AC Immune
- Class Antidementias; Antiulcers; Benzodiazepinones; Gastric antisecretories; Piperazines; Pyridones; Small molecules
- Mechanism of Action BACE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 31 Jan 2013 Discontinued - Phase-II for Alzheimer's disease in Germany and Austria (PO)
- 13 Jun 2011 ACI 91 is still in phase II trials for Alzheimer's disease
- 31 Dec 2008 Phase-II clinical trials in Alzheimer's disease in Germany and Austria (PO)